Novo Nordisk Gulf, headquartered in the United Arab Emirates, represents Novo Nordisk’s presence across the Gulf region, covering the UAE, Kuwait, Qatar, Bahrain, Oman, and Yemen.

As part of Novo Nordisk, a global healthcare company with a heritage of more than 100 years of innovation and leadership in chronic disease care, Novo Nordisk Gulf is committed to driving meaningful change for people living with serious chronic conditions.

With a strong focus on diabetes, obesity, and rare diseases, Novo Nordisk Gulf works closely with healthcare authorities, healthcare professionals, patient organizations, and other key stakeholders to support better disease awareness, early diagnosis, access to care, and improved long-term health outcomes.

Through scientific innovation, strategic partnerships, education initiatives, and a patient-centered approach, Novo Nordisk Gulf continues to contribute to healthier communities and support national healthcare priorities across the region.